Biomimetic Medicine: The Architecture of Peptide Combinations 🧬🧩
One molecule, a tested combination, or an informal stack? The evidence that turns biological inspiration into a defensible therapeutic design.
🎧 Listen to this article:
🧭 What does the second ingredient add?
A second ingredient does more than lengthen a treatment's name. It introduces another claim: that the combination offers something worth adding. An attractive explanation for how two signals might cooperate is the beginning of that argument, not its conclusion.
The previous article examined how to read an individual trial. Combinations add a sharper question: did the experiment test the partnership, or merely the ingredients? That distinction separates a therapeutic design from a list of plausible ideas. The useful question is not how many biological pathways can be named, but what the additional component actually contributes.